CIK: 0001595855 · Show all filings
Period: Q1 2018 (← Previous) (Next →)
Filing Date: May 14, 2018
Total Value ($000): $349,747 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AXGN | AXOGEN INC | 1,715,000 | $62,597 | 17.9% | $3.33 | +822.2% | COM | 05463X106 |
| — | BLUEPRINT MEDICINES | 600,000 | $55,020 | 15.7% | $27.77 | — | COM | 09627Y109 |
| — | LOXO ONCOLOGY | 179,400 | $20,697 | 5.9% | $43.63 | — | COM | 548862101 |
| CDXS | CODEXIS INC | 1,700,600 | $18,706 | 5.3% | $2.93 | +227.3% | COM | 192005106 |
| — | FIBROGEN INC | 360,000 | $16,632 | 4.8% | $26.18 | — | COM | 31572Q808 |
| — | STRONGBRIDGE BIOPHARMA PLC | 1,590,000 | $14,071 | 4.0% | $4.02 | — | COM | G85347105 |
| — | CORIUM INTERNATIONAL INC | 1,065,000 | $12,215 | 3.5% | $8.50 | — | COM | 21887L107 |
| AGIO | AGIOS PHARMACEUTICALS | 130,000 | $10,631 | 3.0% | $43.03 | +79.6% | COM | 00847X104 |
| FENC | FENNEC PHARMACEUTICALS INC | 873,000 | $10,559 | 3.0% | $9.96 | -5.2% | COM | 31447P100 |
| SGMO | SANGAMO BIOSCIENCES INC | 535,000 | $10,165 | 2.9% | $3.76 | +469.1% | COM | 800677106 |
| — | CYMABAY THERAPEUTICS INC | 665,000 | $8,638 | 2.5% | $8.05 | — | COM | 23257D103 |
| — | AMAG PHARMACEUTICALS INC | 420,000 | $8,463 | 2.4% | $20.15 | — | COM | 00163UAA4 |
| — | MIRAGEN THERAPEUTICS INC | 1,060,000 | $7,430 | 2.1% | $7.01 | — | COM | 60463E10E |
| — | DECIPHERA PHARMACEUTICALS INC | 365,000 | $7,314 | 2.1% | $20.04 | — | COM | 24344T101 |
| — | OCULAR THERAPEUTIX INC | 1,111,000 | $7,232 | 2.1% | $6.51 | — | COM | 67576A900 |
| XOMA | XOMA CORP DEL | 320,200 | $6,477 | 1.9% | $6.46 | +333.2% | COM NEW | 98419J206 |
| — | BIOFRONTERA AG | 391,200 | $6,462 | 1.8% | $16.52 | — | SPONSORED ADS | 090758105 |
| ARDX | ARDELYX | 1,135,600 | $5,734 | 1.6% | $7.13 | -12.5% | COM | 039697107 |
| — | AUDENTES THERAPEUTICS INC | 190,000 | $5,709 | 1.6% | $22.19 | — | COM | 05070R104 |
| — | AMARIN CORP PLC | 1,745,000 | $5,252 | 1.5% | $3.50 | — | SPONSORED ADR | 023111206 |
| — | ABLYNX NV | 90,000 | $4,910 | 1.4% | $24.99 | — | SPONSORED ADR | 00372Y905 |
| — | FOAMIX PHARMACEUTICALS LTD | 950,000 | $4,873 | 1.4% | $5.96 | — | SHS | M46135105 |
| VKTX | VIKING THERAPEUTICS INC | 1,100,800 | $4,810 | 1.4% | $4.39 | +26.2% | COM | 92686J106 |
| RARE | ULTRAGENYX PHARMACEUTICALS INC | 80,000 | $4,079 | 1.2% | $49.03 | +2.7% | COM | 90400D108 |
| — | ACHILLION PHARMACEUTICALS INC | 1,095,100 | $4,063 | 1.2% | $3.38 | — | COM | 00448Q201 |
| — | DEPOMED INC | 600,000 | $3,954 | 1.1% | $6.59 | — | COM | 249908104 |
| PTCT | PTC THERAPEUTICS INC | 145,000 | $3,923 | 1.1% | $25.34 | 0.0% | COM | 69366J200 |
| TGTX | TG THERAPEUTICS INC | 274,200 | $3,893 | 1.1% | $12.78 | 0.0% | COM | 88322Q108 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 222,500 | $3,166 | 0.9% | $10.61 | 0.0% | COM | 87164F105 |
| — | CHIMERIX INC | 600,000 | $3,120 | 0.9% | $5.07 | — | COM | 16934W106 |
| QTRX | QUANTERIX CORP | 150,000 | $2,556 | 0.7% | $19.82 | +1.1% | COM | 74766Q101 |
| — | PROTALIX BIOTHERAPEUTICS INC | 3,260,000 | $1,760 | 0.5% | $0.61 | — | COM | 74365A101 |
| — | FORTRESS BIOTECH INC | 315,000 | $1,433 | 0.4% | $4.55 | — | COM | 34960Q109 |
| — | EPIZYME INC | 70,000 | $1,242 | 0.4% | $17.74 | — | COM | 29428V104 |
| — | SYROS PHARMACEUTICALS INC | 74,074 | $961 | 0.3% | $15.97 | — | COM | 87184Q107 |
| — | ZOSANO PHARMA CORP | 100,000 | $504 | 0.1% | $5.04 | — | COM | 98979H103 |
| — | QUOTIENT LTD | 60,000 | $282 | 0.1% | $4.70 | — | SHS | G73268107 |
| — | BIOLINERX LTD | 250,000 | $214 | 0.1% | $1426.15 | — | SPONSORED ADR | 09071M106 |